Additionally, the fact that high glucose enhances TLR4 expression on human monocytes [32] and its higher activity reflects an increasing risk of co-morbidities in patients with MetS [33] raises the question about a beneficial effect of the decreasing TLR4 level. Here, TLR4 is linked to metabolic syndrome.